Fabry Disease

Protocol Name: Observational Study of Safety and Effectiveness of Elfabrio in Fabry Patients Protocol #: CLI-06657AA1-10 (MODERN) Indication: Fabry Disease GFR: n/a Principal Investigator: Ankit N. Mehta, MD, FASN Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204 DETAILS >

Protocol Name: Observational Study Protocol – Fabry Disease Registry Protocol #: DIREGC07006 Indication: Fabry Disease Principal Investigator: Ankit Mehta, MD Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204 DETAILS >